Literature DB >> 15214731

GATC-specific restriction and modification systems in treponemes.

M Piknova1, P Pristas, P Javorsky, A Kasperowic, T Michalowski.   

Abstract

AIMS: To investigate the presence of GATC-specific modification and restriction activities in rumen isolates of Treponema sp.
METHODS: The presence of N6-methyladenine within GATC (Dam) sequences was analysed using isoschizomeric restriction endonucleases having different sensitivities to the methylation of the target sequence. A fast screening method was used for testing of site-specific endonuclease activities directly in crude cell extracts. Three out of six rumen isolates of Treponema sp. showed restriction activities. Restriction endonucleases were further purified by Heparin-Sepharose chromatography. Using PCR and specific primers, no sequence homologous to the T. pallidum dam gene was found.
CONCLUSIONS: Three rumen treponemal strains were documented to possess MboI isoschizomeric restriction-modification systems. SIGNIFICANCE: This is the first report on restriction activity in rumen treponemes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214731     DOI: 10.1111/j.1472-765x.2004.01483.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  3 in total

1.  Limited genetic variability in Megasphaera elsdenii strains.

Authors:  M Piknová; O Bíres; P Javorský; P Pristas
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Antibiotic resistance and restriction endonucleases in fecal enterococci of chamois (Rupicapra rupicapra Linnaeus, 1758).

Authors:  A Vandžurová; I Hrašková; J Júdová; P Javorský; P Pristaš
Journal:  Folia Microbiol (Praha)       Date:  2012-04-17       Impact factor: 2.099

3.  Restriction-modification mediated barriers to exogenous DNA uptake and incorporation employed by Prevotella intermedia.

Authors:  Christopher D Johnston; Chelsey A Skeete; Alexey Fomenkov; Richard J Roberts; Susan R Rittling
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.